Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communications Arising
  • Published:

Bone Metastasis

Can osteoclasts be excluded? (Reply)

Abstract

Martin and Mundy1 emphasize the crucial role played by osteoclasts in the metastasis of many tumour types to bone. Our intention was not to question the importance of osteoclasts in bone metastases, but rather to show that RANK ligand (RANKL) exerts additional action on cancer cells beyond its effects on osteoclasts2. We reported that epithelial tumour cells can express RANK, a finding that is supported by earlier work3; that RANKL has chemotactic activity4; and that in vivo inhibition of RANKL by osteoprotegerin reduces tumour burden in bone when assessed in a previously published experimental system5.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Martin, T. J. & Mundy, G. R. Nature 445, doi: 10.1038/nature05657 (2007).

  2. Jones, D. H. et al. Nature 440, 692–696 (2006).

    Article  ADS  CAS  Google Scholar 

  3. Thomas, R. J. et al. Endocrinology 140, 4451–4458 (1999).

    Article  CAS  Google Scholar 

  4. Mosheimer, B. A., Kaneider, N. C., Feistritzer, C., Sturn, D. H. & Wiedermann, C. J. Arthr. Rheum. 50, 2309–2316 (2004).

    Article  CAS  Google Scholar 

  5. Sanchez-Sweatman, O. H., Lee, J., Orr, F. W. & Singh, G. Eur. J. Cancer 33, 918–925 (1997).

    Article  CAS  Google Scholar 

  6. Sterling, J. A. et al. Cancer Res. 66, 7548–7553 (2006).

    Article  CAS  Google Scholar 

  7. Hiraga, H., Williams, P. J., Mundy, G. R. & Yoneda, T. Cancer Res. 61, 4418–4424 (2001).

    CAS  PubMed  Google Scholar 

  8. Clezardin, P. Cancer Treat. Rev. 31 (suppl), 1–8 (2005).

    Article  Google Scholar 

  9. Wood, J. et al. J. Pharmacol. Exp. Ther. 302, 1055–1061 (2002).

    Article  CAS  Google Scholar 

  10. Kong, Y.-Y. et al. Nature 397, 315–323 (1999).

    Article  ADS  CAS  Google Scholar 

  11. Fata, J. E. et al. Cell 103, 41–50 (2000).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jones, D., Nakashima, T., Sanchez, O. et al. Can osteoclasts be excluded? (Reply). Nature 445, E19–E20 (2007). https://doi.org/10.1038/nature05658

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature05658

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing